Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
3 trials
Recent
Start date
Enrollment
Completed
×
Triple Negative Breast Neoplasms
×
Pemetrexed
×
Clear all
Filters
3
NCT03396445
2025-11-05
MK-5890-001
Merck Sharp & Dohme LLC
Phase 1
Completed
182 enrolled
36 charts
NCT03267316
2024-08-22
CANFOUR
Cantargia AB
Phase 1/2
Completed
167 enrolled
NCT02983045
2023-03-13
PIVOT-02
Nektar Therapeutics
Phase 1/2
Completed
557 enrolled
22 charts